Month: January 2024
ROUYN-NORANDA, Jan. 22, 2024 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to report that Brunswick Exploration Inc. (BRW-TSXV, BRWXF-OTCQB) have started “A Phase II drilling campaign at the Mirage (Lac Escale) project, located in the Eeyou-Istchee James Bay region of Quebec. The winter drill program is targeting extensions of known pegmatite dykes (MR-1 to MR-6) and new prospective outcrops that have yet to be drill-tested.”
“The planned drill holes are distributed over the 2.8 kilometer known strike length to test the entire spodumene-bearing pegmatite dyke swarm”. Previous drilling intersected...
New composition of Ageas’s Executive Committee
Written by Customer Service on . Posted in Public Companies.
New composition of Ageas’s Executive Committee
Today Ageas announces upcoming organisational changes within its Executive Committee with the objective to align its governance model to the strategic ambitions of the Group.
Ageas is reinforcing the Group’s current Executive Committee by including all its 4 business segments (Europe, Asia, Belgium, and Reinsurance), complemented by a newly created function of Managing Director Business Development. The latter function will be responsible for the development and implementation of the Group’s strategy, and for the further evolution of its footprint.
The changes are being implemented to:better reflect the current business profile taking into account the evolving importance and size of the Group’s different activities.
simplify and improve the integration of corporate and business decision...
Reverse share split registered
Written by Customer Service on . Posted in Public Companies.
Oslo, Norway, 22 January 2024
Interoil Exploration and Production ASA (the “Company”) refers to the resolution made by the Company’s Extraordinary General Meeting on 18 December 2023 to do a reverse share split (share consolidation) of the Company’s shares in the ratio of 10:1 to meet Oslo Børs’ requirements of a minimum share value of NOK 1 per share, and the announcement of key information relating to the share consolidation published on 19 January 2024.
The reverse share split has now been registered with the Norwegian Register of Business Enterprises. Following such registration, the Company’s registered share capital is NOK 100,672,140, divided into 20,134,428 shares, each with a par value of NOK 5.00.
This information is subject to the disclosure requirements pursuant to Oslo Rule Book II for companies...
Clinical Nutrition Market Set to Soar Past USD 22.9 Billion by 2030
Written by Customer Service on . Posted in Mergers And Acquisitions.
The global Clinical Nutrition market size is expected to reach USD 22.9 billion by 2030 and exhibit a CAGR of 5% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing prevalence of chronic diseases and disorders, growing geriatric population, rising awareness about the importance of proper nutrition in healthcare, advancements in medical research and technology, expanding product portfolios by key players in the market, government initiatives and policies promoting clinical nutrition, are fueling the Market’s growth.
Westford, USA, Jan. 22, 2024 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Clinical Nutrition Market, personalized nutrition and nutrigenomics, plant-based and vegan clinical nutrition products, clean label and natural ingredients,...
Probiotics Market Size Worth USD 125.55 Billion in 2032 | Emergen Research
Written by Customer Service on . Posted in Mergers And Acquisitions.
Rising adoption of IoT devices and solutions and increasing use of IoT solutions built on blockchain with smart contracts and Artificial Intelligence (AI) are key factors driving Probiotics Market revenue growth
Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) — The global probiotics market size was USD 57.80 Billion in 2022 and is expected to register a revenue CAGR of 8.1% during the forecast period. Growing awareness among customers about gut health, involvement of international organizations in probiotic product Research & Development (R&D), and increasing consumption of probiotics in food and drinks are some of the key factors driving market revenue growth.
Growing awareness among customers regarding gut health is a key factor driving market revenue growth. Consumption of probiotic-rich foods and the use of probiotic supplements...
GYRODYNE ANNOUNCES RECORD DATE FOR PROPOSED RIGHTS OFFERING
Written by Customer Service on . Posted in Public Companies.
ST. JAMES, N.Y., Jan. 22, 2024 (GLOBE NEWSWIRE) — Gyrodyne, LLC (“Gyrodyne” or the “Company”) (NASDAQ: GYRO), an owner and manager of a diversified portfolio of real estate properties, today announced that the record date for its proposed rights offering is January 29, 2024 at 5:00 p.m. Eastern Time (the “Record Date”).
As previously announced, the Company intends to raise up to $5 million in aggregate gross proceeds by way of a rights offering where its existing shareholders as of the Record Date will be granted rights to purchase shares of the Company’s common stock (the “Rights Offering”).
The Company filed a registration statement (File No. 333-276312) (the “Registration Statement”) with respect to the proposed Rights Offering with the Securities and Exchange Commission (the “SEC”) on December 29, 2023. In the Rights Offering,...
Remsleep Holdings Inc.’s DeltaWave Mask has received questions from FDA regarding 510k submission (K233415)
Written by Customer Service on . Posted in Public Companies.
TAMPA, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) — RemSleep Holdings Inc. (OTCQB: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to Obstructive Sleep Apnea (OSA) has received a response to the company’s 510(K) submission K233415. The agency has determined that additional information is required. The agency has asked for additional information regarding Administrative Information, Device Description, Substantial Equivalence (SE), Labeling, Biocompatibility, and Performance testing. All these questions can be answered, and we are in the process of responding with the answers.
The agency has also requested additional Shelf-Life testing for DeltaWave packaging. We are in the process of initiating accelerated Shelf-Life testing for the DeltaWave packaging. This request was a surprise to...
Form 8 (DD) – GCP Asset Backed Income Fund Limited
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8 (DD)
PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
Foresight Group LLP(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
GCP Asset Backed Income Fund Limited(d) Status of person making the disclosure: e.g. offeror, offeree, person acting in concert with...
Peripheral Neuropathy Market Size Worth USD 8.54 Billion in 2032 | Emergen Research
Written by Customer Service on . Posted in Mergers And Acquisitions.
Rise in peripheral neuropathy cases, the increased prevalence of chronic illnesses, and increasing number of pipeline drugs are some of the key factors driving Peripheral Neuropathy market revenue growth
Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) — The global peripheral neuropathy market size was USD 3.61 Billion in 2022 and is expected to register a revenue CAGR of 9.0% during the forecast period. Rise in peripheral neuropathy cases, the increased prevalence of chronic illnesses, and increasing number of pipeline drugs are some of the key factors driving market revenue growth.Increasing number of pipeline drugs is also a major factor expected to continue to drive adoption of peripheral neuropathy, due to large unfilled medical need and the possibility of novel, efficient treatments for peripheral neuropathy. Drugs categorized as...
Bitcoin Depot Places Order for 500 New BTM Kiosks from Kiosk Provider Genmega
Written by Customer Service on . Posted in Public Companies.
BTM Acquisition Will Support the Company’s Bold Expansion Strategy as North America’s Market Share Leader
ATLANTA, Jan. 22, 2024 (GLOBE NEWSWIRE) — Bitcoin Depot (“Bitcoin Depot” or the “Company”) (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced the purchase order of 500 new Bitcoin ATM kiosks from Genmega, a leading manufacturer and provider of ATM and Kiosk solutions with well over 150,000 units deployed worldwide. The Company plans to strategically deploy these units as part of its ongoing expansion efforts throughout 2024 and beyond.
“The purchase order for these kiosks is significant as it demonstrates our ongoing commitment to a bold, strategic, and measured expansion this year,” said Bitcoin Depot CEO Brandon Mintz. “We are deeply committed to delivering a seamless and...
